Merck & Co., Inc. MRK
$115.12
▼ -1.42% 24H
About
Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio features prominent human health pharmaceuticals such as Keytruda for oncology treatments, Welireg for specific cancer t…
SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - General
CountryUnited States
Employees73,000
TickerMRK
Statistics
Market Cap$284.31B
Revenue (TTM)$65.01B
Net Income$18.25B
Net Margin28.1%
EPS$7.28
P/E33.55
P/S4.47
P/B6.41
EV/EBITDA11.44
ROE18.9%
Dividend Yield2.86%
Price$115.12
Data: Twelve Data · Revenue = mcap / P/S